| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/03/2010 | CN101663318A Antibodies specific for varicella zoster virus |
| 03/03/2010 | CN101659703A Monoclonal antibody of anti-human BAP31 protein, preparation method and application thereof |
| 03/03/2010 | CN101659702A Monoclonal antibody of anti-human calnexin protein, preparation method and application thereof |
| 03/03/2010 | CN101658672A Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents |
| 03/02/2010 | US7671189 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
| 03/02/2010 | US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents |
| 03/02/2010 | US7671179 Substituting an amino acid within the variable domain of the heavy or light chain of the monoclonal antibody wherein above amino acid containing a nonpolar side chain, with a proline |
| 03/02/2010 | US7671176 host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity; for identifying mu3 opiate receptor agonists and antagonists |
| 03/02/2010 | US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+. |
| 03/02/2010 | US7671027 use of agonist of hypothalamic hormone, i.e. GnRH, for preparation to support luteal phase during infertility treatment of female mammals; pharmaceutical agent supports luteal phase after spontaneous ovulation or after stimulation of follicular growth triggering final follicular maturation and ovulation |
| 03/02/2010 | US7671022 administering molecules that block endogenous costimulatory (B7) interactions with cytotoxic t lymphocytes(CTLA4) and/or CD28 antigens |
| 03/02/2010 | US7670835 diagnosis of and vaccination against Streptococcal infections ; detection of virulence markers of Streptococci |
| 03/02/2010 | US7670826 Belonging to subfamily of human immunoglobulin superfamily; isolated antibodies and nucleic acids; transformed host cells; modulating transendothelial migration of leukocytes; inflammation, tumors |
| 03/02/2010 | US7670816 UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1 |
| 03/02/2010 | US7670805 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 03/02/2010 | US7670804 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 03/02/2010 | US7670781 Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal |
| 03/02/2010 | US7670766 Early detection of flaviviruses using the NS1 glycoprotein |
| 03/02/2010 | US7670631 Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| 03/02/2010 | US7670610 Recombinant BCG vaccine |
| 03/02/2010 | US7670602 Concatameric immunoadhesion molecule |
| 03/02/2010 | US7670600 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 03/02/2010 | US7670599 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy |
| 02/25/2010 | WO2010022279A1 Antibodies and related molecules that bind to 58p1d12 proteins |
| 02/25/2010 | WO2010022145A2 Alternatively-spliced isoform of mu-opioid receptor gene with cell excitatory function |
| 02/25/2010 | WO2010022120A1 Human antibodies to human rankl |
| 02/25/2010 | WO2010021822A2 Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites |
| 02/25/2010 | WO2010021697A2 Antibodies to ccr2 |
| 02/25/2010 | WO2010020766A2 Interleukin fusion polypeptides |
| 02/25/2010 | WO2010020669A1 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
| 02/25/2010 | WO2010020143A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 02/25/2010 | WO2010019997A1 Monoclonal antibody stro-4 |
| 02/25/2010 | WO2010003108A3 TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 02/25/2010 | WO2009150255A3 Markers for predicting response and survival in anti-egfr treated patients |
| 02/25/2010 | WO2009140348A4 Anti-il-6/il-6r antibodies and methods of use thereof |
| 02/25/2010 | WO2009140236A3 Staphylococcus aureus-specific antibody preparations |
| 02/25/2010 | WO2009138494A3 Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors |
| 02/25/2010 | WO2009135118A3 Lyme disease vaccine |
| 02/25/2010 | WO2009132251A9 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies |
| 02/25/2010 | WO2009118660A3 Adam-15 antibodies and immunogenic peptides |
| 02/25/2010 | WO2009013621A3 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100050296 Preparation of organisms with faster growth and/or higher yield |
| 02/25/2010 | US20100050278 Application of Actin-Binding Protein to Disease Associated With Cell Motility |
| 02/25/2010 | US20100048878 Human gene |
| 02/25/2010 | US20100048877 Novel multivalent immunoglobulins |
| 02/25/2010 | US20100048876 Chromatography ligand comprising domain c from staphylococcus aureus protein a for antibody isolation |
| 02/25/2010 | US20100048863 Growth factor which acts through erb b-4 rtk |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048456 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/25/2010 | US20100047922 Turbidimetric immunoassay for assessing human cystatin c |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047877 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 02/25/2010 | US20100047867 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 02/25/2010 | US20100047863 Group of novel enantiosleective microbial nitrile hydratases with broad substrate specificity |
| 02/25/2010 | US20100047830 Compositions and methods for detecting cancers in a subject |
| 02/25/2010 | US20100047829 Activated her3 as a marker for predicting therapeutic efficacy |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047812 Peptide antibody depletion and its application to mass spectrometry sample preparation |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047798 Adenosine a1 and a3 receptor gene sequence variations for predicting disease outcome and treatment outcome |
| 02/25/2010 | US20100047772 Compounds, compositions and methods for the treatment of diseases characterized by a-33 related antigens |
| 02/25/2010 | US20100047770 Detection of Breast Cancer |
| 02/25/2010 | US20100047764 Novel surface protein (HBsAg) variant of the hepatitis B virus |
| 02/25/2010 | US20100047392 Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them |
| 02/25/2010 | US20100047287 Outer membrane vesicles and uses thereof |
| 02/25/2010 | US20100047282 method of accelerated vaccination against ebola viruses |
| 02/25/2010 | US20100047278 Human Rotavirus and Vaccine Composition Comprising Same |
| 02/25/2010 | US20100047273 Coxsackie B virus and type 1 diabetes |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/25/2010 | US20100047258 Drug Carriers, Their Synthesis, and Methods of Use Thereof |
| 02/25/2010 | US20100047257 Antagonist antibody for the treatment of cancer |
| 02/25/2010 | US20100047252 Antibody with protein a selectivity |
| 02/25/2010 | US20100047251 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 02/25/2010 | US20100047247 Nerve elongation promoter and elongation inhibitor |
| 02/25/2010 | US20100047245 Complementary determining regions (CDR); interleukins (IL-12) |
| 02/25/2010 | US20100047244 Human CTLA-4 Antibodies and Their Uses |
| 02/25/2010 | US20100047243 Novel antibodies against igf-ir |
| 02/25/2010 | US20100047241 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 02/25/2010 | US20100047239 Dual variable domain immunoglobulin and uses thereof |
| 02/25/2010 | US20100047238 Humanized antibodies against |
| 02/25/2010 | US20100047237 Prevention of aggregation of immunoglobulin light or heavy chains |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047230 Anti her2/neu antibody |
| 02/25/2010 | US20100047171 Fusion Proteins That Contain Natural Junctions |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | US20100047166 Antibodies and related molecules that bind to 58p1d12 proteins |
| 02/25/2010 | US20100047164 Anti-Tumor Antibodies |
| 02/25/2010 | CA2734838A1 T cell receptors and related materials and methods of use |
| 02/25/2010 | CA2734800A1 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
| 02/25/2010 | CA2734578A1 Antibodies to ccr2 |
| 02/25/2010 | CA2734210A1 Monoclonal antibody stro-4 |
| 02/25/2010 | CA2732493A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 02/24/2010 | EP2157178A1 Antibody against von Willebrand Factor cleaving enzyme and assay system using the same |
| 02/24/2010 | EP2157102A1 Antibodies against tenascin-C |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2155791A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity |
| 02/24/2010 | EP2155790A1 Method for extending the half-life of exogenous or endogenous soluble molecules |